HIF1A and hepatocellular carcinoma: To the best of our knowledge, we demonstrated, for the first time, that the antitumor effects resulted from oxidative stress induced by the combination therapy of HIF-1α inhibition and a ketogenic diet in hypoxic HCC cells, which may be a novel therapeutic choice.